Peter Devilee Selected Research

Familial Breast Cancer

11/2017	PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.
9/2015	FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.
2/2015	Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.
1/2013	Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.
12/2003	The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Devilee Research Topics

Disease

82	Breast Neoplasms (Breast Cancer) 06/2023 - 05/2002
57	Neoplasms (Cancer) 09/2023 - 12/2003
20	Paraganglioma (Paragangliomas) 01/2023 - 05/2004
14	Pheochromocytoma 01/2023 - 11/2005
6	Carcinogenesis 01/2022 - 05/2009
5	Familial Breast Cancer 11/2017 - 12/2003
4	Ovarian Neoplasms (Ovarian Cancer) 02/2016 - 02/2011
3	Genetic Risk Score 11/2020 - 05/2015
2	Triple Negative Breast Neoplasms 01/2023 - 01/2019
2	Hypersensitivity (Allergy) 11/2015 - 12/2013
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 07/2015 - 07/2012
2	Inflammation (Inflammations) 06/2014 - 07/2009
2	Glioblastoma (Glioblastoma Multiforme) 01/2012 - 06/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021
1	Disease Progression 01/2020
1	Chromosome Fragility 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Obesity 01/2018
1	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Smooth Muscle Tumor 11/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2015
1	Polyps 06/2015
1	Endometrial Neoplasms (Endometrial Cancer) 09/2014
1	Neoplasm Metastasis (Metastasis) 03/2014

Drug/Important Bio-Agent (IBA)

36	Estrogen ReceptorsIBA 05/2023 - 07/2005
23	Proteins (Proteins, Gene)FDA Link 06/2023 - 05/2002
19	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 03/2007
18	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2023 - 05/2004
10	Hormones (Hormone)IBA 01/2019 - 10/2010
7	Progesterone Receptors (Progesterone Receptor)IBA 03/2022 - 05/2009
4	EnzymesIBA 01/2022 - 09/2007
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2013
3	Phosphotransferases (Kinase)IBA 01/2022 - 05/2002
3	3' Untranslated Regions (3' UTR)IBA 01/2016 - 01/2014
3	Fumarate Hydratase (Fumarase)IBA 11/2015 - 09/2007
3	Sp1 Transcription FactorIBA 09/2014 - 02/2011
2	Phenobarbital (Luminal)FDA Link 10/2022 - 01/2020
2	ORALIT (ORS)IBA 03/2022 - 05/2009
2	Succinic Acid (Succinate)IBA 01/2022 - 09/2007
2	human ERBB2 proteinIBA 01/2022 - 01/2020
2	ElementsIBA 01/2021 - 07/2012
2	Tricarboxylic AcidsIBA 01/2021 - 11/2015
2	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2012
2	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2014
2	Genetic Markers (Genetic Marker)IBA 01/2016 - 05/2015
2	ChromatinIBA 01/2016 - 01/2015
2	Histones (Histone)IBA 11/2015 - 10/2009
2	LuciferasesIBA 07/2015 - 04/2013
2	Tumor Biomarkers (Tumor Markers)IBA 07/2015 - 02/2011
2	RNA (Ribonucleic Acid)IBA 07/2015 - 05/2009
2	NucleotidesIBA 04/2015 - 05/2003
2	Aurora Kinase AIBA 01/2015 - 07/2007
1	RNA Precursors (Precursor, mRNA)IBA 09/2023
1	Long Noncoding RNAIBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2022
1	Checkpoint Kinase 2IBA 01/2022
1	Ataxia Telangiectasia Mutated ProteinsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2020
1	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	diepoxybutaneIBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019
1	olaparibIBA 01/2019
1	sperm releasing substanceIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2018
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 11/2017
1	Codon (Codons)IBA 02/2016
1	Death Domain ReceptorsIBA 01/2016
1	Exonucleases (3' 5' Exonuclease)IBA 01/2016
1	5-hydroxymethylcytosineIBA 11/2015
1	histone H3 trimethyl Lys4IBA 11/2015
1	Type I Tumor Necrosis Factor ReceptorsIBA 11/2015
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2015
1	Deoxyribonuclease I (Nickase)IBA 11/2015
1	MucinsIBA 11/2015
1	Nonsense Codon (Nonsense Mutation)IBA 09/2015
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 07/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2015
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2015
1	CytokinesIBA 03/2014
1	Indicators and Reagents (Reagents)IBA 03/2014
1	Member 1 Group A Nuclear Receptor Subfamily 4IBA 03/2014
1	DNA Glycosylases (DNA Glycosylase)IBA 01/2014
1	Deoxyribonuclease (Pyrimidine Dimer)IBA 01/2014
1	GuanineIBA 01/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2014
1	Deoxyribonucleases (DNase)FDA Link 12/2013
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2013
1	Cyclin D1IBA 04/2013

Therapy/Procedure

3	Radiotherapy 02/2023 - 01/2019
3	Mastectomy (Mammectomy) 08/2021 - 10/2019
1	Therapeutics 01/2018
1	Drug Therapy (Chemotherapy) 06/2014